Overall survival and central nervous system activity of crizotinib in ROS1-rearranged lung cancer-final results of the EUCROSS trial
克唑替尼治疗ROS1重排肺癌的总体生存率和中枢神经系统活性——EUCROSS试验的最终结果
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.102237
Michels, S; Massutí, B; Vasyliv, I; Stratmann, J; Frank, J; Adams, A; Felip, E; Grohé, C; Rodriguez-Abreu, D; Bischoff, H; Carcereny I Costa, E; Corral, J; Pereira, E; Fassunke, J; Fischer, R N; Insa, A; Koleczko, S; Nogova, L; Reck, M; Reutter, T; Riedel, R; Schaufler, D; Scheffler, M; Weisthoff, M; Provencio, M; Merkelbach-Bruse, S; Hellmich, M; Sebastian, M; Büttner, R; Persigehl, T; Rosell, R; Wolf, J